Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Curriculum Vitae Jeffery T. Zobell, Pharm.D. 73 East 550 South Kaysville, UT 84037 (801) 547-0505 [email protected] Education 2002-2006 The University of Arizona, Tucson, Arizona Doctor of Pharmacy Employment 2009-present Team Leader-Children’s Medical/Surgical Unit; Infant Medical/Surgical Unit, Intermountain Primary Children’s Hospital, Intermountain Healthcare, Salt Lake City, Utah Start Date: July 2009. Responsibilities: Clinical floor pharmacist, attending inter-disciplinary rounds, patient-family medication education, pharmacokinetics, precepting residents and students, project preceptor for resident projects 2009-present Clinical Pharmacist, Intermountain Cystic Fibrosis Pediatric Center, Salt Lake City, Utah Start Date: July 2009. Responsibilities: Preceptor for Cystic Fibrosis ambulatory care pharmacy practice residency, patientfamily medication education, quality improvement and clinical research projects 2008-2009 Neonatal Intensive Care Unit Pharmacist, Intermountain Primary Children’s Medical Center, Intermountain Healthcare, Salt Lake City, Utah 2007-2008 General Clinical Pharmacist, Intermountain Primary Children’s Medical Center, Intermountain Healthcare, Salt Lake City, Utah 2006-2007 Pharmacy Practice Resident, Intermountain Primary Children’s Medical Center, Intermountain Healthcare, Salt Lake City, Utah 2002-2006 Pharmacy Intern, Banner Desert Pharmacy, Banner Desert Medical Center, Banner Health System, Mesa, Arizona 2000-2002 Pharmacy Technician, Banner Desert Pharmacy, Banner Desert Medical Center, Banner Health System, Mesa, Arizona 5/8/2017 Publications Louie JM, Young DC, Zobell JT, Bhakta ZN, et al. Safety of continuous infusion betalactam antibiotics in adult cystic fibrosis patients during an acute pulmonary exacerbation. Pediatr Pulmonol. 2014; Suppl 38:329. Zobell JT, Ferdinand C, Kemper A, Gorney N, et al. Efficacy of high dose vs. standard dose of ceftazidime in pediatric CF patients. Pediatr Pulmonol. 2014; Suppl 38:305 Zobell JT, Epps K, Kittell F, Sema C, et al. Antibiotic utilization in CF exacerbations: a pharmacist approach. Pediatr Pulmonol. 2014; Suppl 38:303 Holcomb KA, Young DC, Zobell JT, Bhakta ZN, et al. Survey of antibiotic utilization for treatment of Mycobacterium abscessus infection amongst CF accredited care centers. Pediatr Pulmonol. 2014; Suppl 38:285 Zobell JT, Epps K, Young DC, Montague M, Olson J, Ampofo K, Chin M, Marshall BC, Dasenbrook E. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in CF patients. Pediatr Pulmonol. Article in press. Hunt T, Zobell JT, MacKay M, McDonald CM, et al. Sterility analysis of cystic fibrosis liquid multivitamins. Pediatr Pulmonol. 2013; Suppl 36:299 Zobell JT, Darnell L, Ferdinand C, Kemper A, et al. High dose intermittent ceftazidime administration in pediatric cystic fibrosis patients. Pediatr Pulmonol. 2013; Suppl 36:293. Zobell JT, Epps K, Young DC, Hatch M, et al. Utilization of antibiotics for methicillinresistant Staphylococcus aureus infection in CF patients. Pediatr Pulmonol. 2013; Suppl 36:294. Bhakta ZN, Young DC, Zobell JT, Kuhn RJ, et al. A survey of the pharmacist’s role at US CFF-accredited centers—a director’s perspective. Pediatr Pulmonol. 2013; Suppl 36:518. Chatfield BA, Zobell JT, Stewart J, Hamilton J. Improved delivery time from inpatient admission to antibiotic administration for the CF patient. Pediatr Pulmonol. 2013; Suppl 36:650. Young DC, Zobell JT, Kuhn RJ, Chin M, et al. A survey of pharmacists providing care at US CFF-accredited centers. Pediatr Pulmonol. 2013; Suppl 36:653. Sherwin CMT, Zobell JT, Stockmann C, McCrory BE, et al. Pharmacokinetic and pharmacodynamic optimization of intravenous tobramycin dosing among children with cystic fibrosis. J Pharmacokinet Pharmacodyn. 2014;41(1):71-9. 5/8/2017 Jeffery Zobell 3 Stockman C, Sherwin CMT, Zobell JT, Lubsch, L, et al. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Pharmacother. 2013; 33(12):1288-96. Zobell JT, Kemper AL, Young DC. The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages. Pediatr Pulmonol. 2014;49(3):E48-51 Zobell JT, Young DC, Waters CD, Stockmann C, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary. Pediatr Pulmonol. 2013; 48:525-537. Young DC, Zobell JT, Stockmann C, Waters CD, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. aminoglycosides. Pediatr Pulmonol. 2013; 48(11):1047-1061. Zobell JT, Ferdinand C, Young DC. Continuous infusion meropenem and ticarcillinclavulanate in pediatric cystic fibrosis patients. Pediatr Pulmonol. 2014;49(3):302-6 Young DC, Zobell JT, Waters CD, Ampofo K, et al. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium. Pediatr Pulmonol. 2013; 48(1):1-7. Stockmann C, Sherwin C, Zobell JT, Young DC, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones. Pediatr Pulmonol. 2013; 48(3):211-220. Zobell JT, Waters CD, Young DC, Stockmann, C, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins. Pediatr Pulmonol. 2013; 48(2):107-122. Zobell JT, Young DC, Waters CD, Stockmann C, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems. Pediatr Pulmonol. 2012; 47(12):1147-1158. Zobell JT, Young DC, Chatfield BA. Intermittent and extended-infusion beta-lactam utilization in cystic fibrosis. Pediatr Pulmonol. 2013; 48:622-623. Pohl JF, Zobell J, Lin E, Korgenski K, et al. Clostridium difficile infection and proton pump inhibitor use in hospitalized pediatric cystic fibrosis patients. Gastroenterol Res Pract. 2011; 2011:345012. Zobell JT, Stockmann C, Young DC, Cash J, et al. Population pharmacokinetic and pharmacodynamic modeling of high dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. Clin Ther. 2011; 33:1844-1850. 5/8/2017 Jeffery Zobell 4 Leonard W, Zobell JT, Ensign R, Korgenski K, et al. Retrospective evaluation of appropriate duration of intravenous antibiotic therapy for acute CF exacerbations. Pediatr Pulmonol. 2011; Suppl 34:330 Zobell JT, Stockmann C, Young DC, Cash J, et al. Population pharmacokinetic (PK) and pharmacodynamic (PD) modeling of ticarcillin-clavulanate in pediatric CF patients. Pediatr Pulmonol. 2011; Suppl 34:277 Zobell JT, Young D, Waters CD, Ampofo K, et al. A survey of the utilization of antipseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol. 2011; 46:987-990. Zobell JT, Ampofo K, Cash J, Korgenski K, Chatfield BA. High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. J Cyst Fibros. 2010; 9:280-283. Lin E, Zobell J, MacKay M, Korgenski K, et al. Role of acid suppression as a risk factor in Clostridium difficle infections in pediatric CF patients. Pediatr Pulmonol. 2009; Suppl 32:526. Chatfield BA, Zobell J, Seidelman J, Mundorf M, et al. Compliance in prescribing of CF medications of a CF specific medication tracker. Pediatr Pulmonol. 2009; Suppl 32:508 Halton K, Zobell J, MacKay M, Ensign R, et al. Evaluation of the effectiveness of a MRSA eradication protocol in pediatric CF patients. Pediatr Pulmonol. 2009; Suppl 32:366. Zobell J, Olson J, Cash J, Mitchell M, et al. Evaluation of a change in once daily tobramycin pharmacokinetic monitoring in pediatric CF patients. Pediatr Pulmonol. 2009; Suppl 32:493. Zobell JT, Hoopes L, Hyer J, MacKay M, et al. Prospective evaluation of the delivery of intravenous antibiotics during CF exacerbations. Pediatr Pulmonol. 2008; Suppl 31:575 McDonald K, Zobell J, MacKay M. Vitamin D status in children with CF. Pediatr Pulmonol. 2008; Suppl 31:656. Zobell, JT, Hyer J, MacKay M, Koopmeiners K, et al. Improving delivery of intravenous antibiotics during CF exacerbations. Pediatr Pulmonol. 2007; Suppl 30:370. Chatfield BA, Seidelman J, Hyer JS, Zobell JT, et al. Medtracker: utilizing a patient medication tracking system to improve quality of care in a pediatric cystic fibrosis clinic. Pediatr Pulmonol. 2007; Suppl 30:370-1. 5/8/2017 Jeffery Zobell 5 Presentations Oct 2014 Difficult to Treat Infections: Methicillin-resistant S. aureus (MRSA). Short course session. North American Cystic Fibrosis Conference, Atlanta, Georgia Oct 2014 Research & Collaboration: What Are CF Pharmacists Doing? ACPE-accredited continuing education presentation at the pharmacist caregiver session at the North American Cystic Fibrosis Conference, Atlanta, Georgia Aug 2014 Cystic Fibrosis in Pediatrics. Seminar presentation to 3rd year medical students at the University of Utah School of Medicine, Salt Lake City, Utah July 2014 Update on Pediatric Asthma. Seminar presentation to family practice residents at University of Utah School of Medicine, Salt Lake City, Utah. Feb 2014 Cystic Fibrosis 101: What the Pharmacist Needs to Know. ACPEaccredited continuing education presentation webinar for Walgreen’s and Cystic Fibrosis Services pharmacists, Deerfield, Illinois Oct 2013 Clinical Controversies in CF Care for Pharmacists. ACPEaccredited continuing education presentation at the pharmacist caregiver session at the North American Cystic Fibrosis Conference, Salt Lake City, Utah Oct 2013 Optimization of Anti-pseudomonal and Anti-staphylococcal Antibiotics in CF Exacerbations. Short Course session. North American Cystic Fibrosis Conference, Salt Lake City, Utah May 2013 Optimization of Anti-pseudomonal Antibiotics in CF Pulmonary Exacerbations. Pulmonary and Critical Care Grand Rounds, Utah Valley Regional Medical Center, Provo, Utah Feb 2013 Optimization of Beta-lactam Antibiotics in Cystic Fibrosis and Beyond: Intermittent and Extended/Continuous Infusions. Pediatric Grand Rounds, Intermountain Primary Children’s Medical Center, Salt Lake City, Utah Jan 2013 Update on Pediatric Asthma. Seminar presentation to family practice residents at University of Utah School of Medicine, Salt Lake City, Utah. 5/8/2017 Jeffery Zobell 6 Oct 2012 Pharmacists Collaborating to Optimize Anti-staphylococcal and Anti-pseudomonal Antibiotic Utilization in CF: Optimization of Intermittent Anti-pseudomonal Beta-Lactams. ACPE-accredited continuing education presentation at the pharmacist caregiver session at the North American Cystic Fibrosis Conference, Orlando, Florida Oct 2012 Optimization of Intermittent Anti-pseudomonal Beta-lactams in Acute Pulmonary Exacerbations. Short-Course session. North American Cystic Fibrosis Conference. Orlando, Florida. Apr 2012 Pro-Con: Continuous Infusion vs. Scheduled Antibiotics. ACPEaccredited continuing education at 2012 Pediatric Pharmacy Advocacy Group Conference, Houston, Texas Nov 2011 Leonard W, Zobell JT, Ensign R, Korgenski K, Chatfield BA. Retrospective Evaluation of Appropriate Duration of Intravenous Antibiotic Therapy for Acute CF Exacerbations. Workshop session presentation. North American Cystic Fibrosis Conference. Anaheim, California. Nov 2011 Rational Approach to Treating Infection in Pulmonary Exacerbations—Symposium Co-Chair. Symposium #10 North American Cystic Fibrosis Conference. Anaheim, California. Sept 2011 Basics of Pediatrics. Lecture to 3rd year pharmacy students at the University of Arizona College of Pharmacy, Tucson, Arizona July 2011 Update on Pediatric Asthma. Seminar presentation to family practice residents at University of Utah School of Medicine, Salt Lake City, Utah. May 2011 Childhood vs. Adult Onset Asthma. 26th Annual Advances in Respiratory Care Conference. Las Vegas, Nevada Nov 2010 Childhood vs. Adult Onset Asthma. CME-accredited continuing education for Utah Telehealth Series. Salt Lake City, Utah Oct 2010 Continuous Infusion Beta-Lactam Therapy for Management of Acute Exacerbations in Cystic Fibrosis: Lessons Learned. ACPEaccredited continuing education at 2010 Pediatric Pharmacy Advocacy Group Conference, St. Charles, Missouri Oct 2009 Starting From Scratch: The Process of Developing Pharmacy Services in a Pediatric CF Center. ACPE-accredited continuing 5/8/2017 Jeffery Zobell 7 education presentation at the pharmacist caregiver session at the North American Cystic Fibrosis Conference, Minneapolis, Minnesota Oct 2008 Cryptosporidium and other GI Pathogens in CF: Coming to a POOL near you. ACPE-accredited continuing education presentation at the pharmacist caregiver session at the North American Cystic Fibrosis Conference, Orlando, Florida Oct 2008 Zobell JT, Hoopes L, Hyer J, MacKay M, Koopmeiners K, Hamilton J, Pfitzner M, Chatfield BA. Prospective evaluation of the delivery of intravenous antibiotics during CF exacerbations. Workshop session presentation. North American Cystic Fibrosis Conference, Orlando, Florida Oct 2008 Basics of Pediatrics. Lecture to 3rd year pharmacy students at the University of Arizona College of Pharmacy, Tucson, Arizona April 2008 Update of Pediatric Asthma. ACPE-accredited continuing education presentation at Utah Pharmacists Association annual meeting, St. George, Utah. April 2007 The Ins and Outs of Cystic Fibrosis: A Pharmacy Perspective. ACPE-accredited Continuing Education presentation at Intermountain Primary Children’s Medical Center, Salt Lake City, Utah. March 2007 Update on Pediatric Asthma. Seminar presentation to family practice residents at University of Utah School of Medicine, Salt Lake City, Utah. Oct 2006 LABAs: Is the Black Box Warning Warranted? Seminar presentation to clinical pharmacy staff at Intermountain Primary Children’s Medical Center, Salt Lake City, Utah. Posters Dec 2014 MacKay MW, Anderson C, Zobell J, Cash J, Boehme S. Frequency and Severity of Parenteral Nutrition Medication Errors at a Large Children’s Hospital after Implementation of Electronic Ordering and Compounding. American Health-Systems Pharmacy Midyear Meeting, Anaheim , California Oct 2014 Holcomb KA, Young DC, Zobell JT, Bhakta Z, Marshall B, Olivier K, Nick J, Saiman L. Survey of Antibiotic Utilization for Treatment of Mycobacterium abscessus Infection Amongst Cystic 5/8/2017 Jeffery Zobell 8 Fibrosis Foundation (CFF)-Accredited Care Centers. North American Cystic Fibrosis Conference, Atlanta, Georgia Oct 2014 Louie JM, Young DC, Zobell JT, Bhakta Z, Nickman N, Stevens V, Biltaji E, Carveth H, Liou TG. Safety of Continuous Infusion Beta-Lactam Antibiotics in Adult Cystic Fibrosis Patients During an Acute Pulmonary Exacerbation. North American Cystic Fibrosis Conference, Atlanta, Georgia Oct 2014 Zobell JT, Ferdinand C, Kemper A, Gorney N, Leonard W, Olson J. Efficacy of High Dose vs. Standard Dose Ceftazidime in Pediatric CF Patients. North American Cystic Fibrosis Conference, Atlanta, Georgia Oct 2014 Zobell JT, McDade EJ, Peters SJ, Duval MA, Epps K, Kittell F, Sema C, Pettit RS. Antibiotic Utilization in CF Exacerbations: A Pharmacist Approach. North American Cystic Fibrosis Conference, Atlanta, Georgia Oct 2013 Chatfield BA, Zobell JT, Stewart J, Hamilton J. Improved Delivery Time from Inpatient Admission to Antibiotic Administration for the CF Patient. North American Cystic Fibrosis Conference, Salt Lake City, Utah Oct 2013 Hunt T, Zobell JT, MacKay M, McDonald CM, Olson J, Dickey M, Phillips A, Daly J, Chatfield BA. Sterility Analysis of Cystic Fibrosis Liquid Multivitamins. North American Cystic Fibrosis Conference, Salt Lake City, Utah Oct 2013 Bhakta ZN, Young DC, Zobell JT, Kuhn RJ, Sabadosa K, Chin M, Marshall BC. A Survey of the Pharmacist’s Role at US CFFAccredited Centers – A Director’s Perspective. North American Cystic Fibrosis Conference, Salt Lake City, Utah Oct 2013 Young DC, Zobell JT, Kuhn RJ, Chin M, Marshall B. A Survey of Pharmacists Providing Care at US CFF-Accredited Centers. North American Cystic Fibrosis Conference, Salt Lake City, Utah Oct 2013 Zobell JT, Darnell L, Ferdinand C, Kemper A, Olson J, Chatfield BA. High Dose Intermittent Ceftazidime Administration in Pediatric Cystic Fibrosis Patients. North American Cystic Fibrosis Conference, Salt Lake City, Utah Oct 2013 Zobell JT, Epps K, Young DC, Hatch M, Olson J, Ampofo K, Chin M, Marshall B, Dasenbrook EC. Utilization of Antibiotics for Methicillin-Resistant Staphylococcus Aureus Infection in CF 5/8/2017 Jeffery Zobell 9 Patients. North American Cystic Fibrosis Conference, Salt Lake City, Utah May 2013 Stockmann C, Sherwin C, Zobell J, Lubsch L, Young D, Olson J, Noyes B, Ampofo K, Spigarelli M. Population Pharmacokinetics of Vancomycin Used in the Treatment of Pediatric Cystic Fibrosis Pulmonary Exacerbations. American Conference on Pharmacometrics, Fort Lauderdale, Florida May 2013 Sherwin C, Stockmann C, Zobell J, McCrory B, Wisdom M, Young D, Olson J, Ampofo K, Spigarelli M. A Pharmacokinetic Evaluation of Tobramycin Administered One, Two, and Three Times Daily to Children with Cystic Fibrosis. American Conference on Pharmacometrics, Fort Lauderdale, Florida Nov 2011 Zobell JT, Stockmann C, Young DC, Cash J, et al. Population pharmacokinetic (PK) and pharmacodynamic (PD) modeling of ticarcillin-clavulanate in pediatric CF patients. Poster presentation. North American Cystic Fibrosis Conference, Anaheim, California Nov 2011 Leonard W, Zobell JT, Ensign R, Korgenski K, et al. Retrospective evaluation of appropriate duration of intravenous antibiotic therapy for acute CF exacerbations. Poster presentation. North American Cystic Fibrosis Conference, Anaheim, California Dec 2010 Bennett W, Zobell J, Korgenski K, Chatfield B. Retrospective evaluation of the appropriate duration of intravenous antibiotic therapy for acute exacerbations of cystic fibrosis. Poster presentation. ASHP Mid-year meeting, Anaheim, California Dec 2010 MacKay M, Gerdy C, Keyser B, Andrews S, Zobell J. Understanding missing doses in a pediatric hospital. Poster presentation. ASHP Mid-year meeting, Anaheim, California. Oct 2009 Lin E, Zobell J, MacKay M, Korgenski K, Daly J, Ensign R, Chatfield BA. Retrospective analysis of the role of proton pump inhibitors as a risk factor in Clostridium difficile infections in pediatric cystic fibrosis patients. Poster presentation. North American Cystic Fibrosis Conference, Minneapolis, Minnesota Oct 2009 Halton K, Zobell J, MacKay M, Ensign R, Chatfield BA. Evaluation of the effectiveness of a Staphylococcus aureus eradication/treatment protocol in pediatric cystic fibrosis patients. Poster presentation. North American Cystic Fibrosis Conference, Minneapolis, Minnesota 5/8/2017 Jeffery Zobell 10 Oct 2009 Chatfield BA, Zobell J, Seidelman J, Mundorf M, Richards K. Compliance in prescribing of CF medications of a CF specific medication tracker. Poster presentation. North American Cystic Fibrosis Conference. Minneapolis, Minnesota Oct 2009 Zobell J, Olson J, Cash J, Mitchell M, et al. Evaluation of a change in once daily tobramycin pharmacokinetic monitoring in pediatric CF patients. Poster presentation. North American Cystic Fibrosis Conference. Minneapolis, Minnesota Oct 2008 Zobell JT, Hoopes L, Hyer J, MacKay M, Koopmeiners K, Hamilton J, Pfitzner M, Chatfield BA. Prospective evaluation of the delivery of intravenous antibiotics during CF exacerbations. Poster presentation. North American Cystic Fibrosis Conference, Orlando, Florida Oct 2008 McDonald K, Zobell J, MacKay M. Vitamin D status in children with CF. Poster presentation. North American Cystic Fibrosis Conference, Orlando, Florida Oct 2007 Zobell JT, Hyer J, MacKay M, Koopmeiners K, Chatfield BA. Improving delivery of intravenous antibiotics during CF exacerbations. Poster presentation. North American Cystic Fibrosis Conference, Anaheim, California. Oct 2007 Chatfield BA, Siedelman J, Hyer JS, Zobell, JT, Zakrzewski D, Richards, K. Medtracker: Utilizing a patient medication tracking system to improve quality of care in a pediatric cystic fibrosis clinic. Poster presentation. North American Cystic Fibrosis Conference, Anaheim, California. May 2007 Zobell JT, Boehme S, MacKay M, Hight S, Hight M. Retrospective analysis of a heparin dosing protocol at a tertiary pediatric medical center. Poster presentation. Western States Residency Conference, Asilomar, California. Dec 2006 Zobell JT, Boehme S, MacKay M, Hight S, Hight M. Retrospective analysis of a heparin dosing protocol at a tertiary pediatric medical center. Poster presentation. ASHP Mid-year meeting, Anaheim, California. Electronic Databases Lexi-Comp® Online 5/8/2017 Jeffery Zobell 11 Cystic Fibrosis dosing information for aztreonam, cefepime, ceftazidime, colistimethate sodium, imipenem-cilastatin, meropenem, piperacillin-tazobactam, and ticarcillin-clavulanate drug monographs Up to Date® Cystic Fibrosis dosing information for aztreonam, cefepime, ceftazidime, colistimethate sodium, imipenem-cilastatin, meropenem, piperacillin-tazobactam, and ticarcillin-clavulanate drug monographs Research The Impact of Individualized, Pharmacist-provided Asthma Education in an Asthma Care Pharmacy Co-Principal Investigator Multi-centered, prospective, observational study Intermittent Vancomycin Administration in Cystic Fibrosis Patients Principal Investigator Multi-centered, retrospective pharmacokinetic and pharmacodynamic analysis Pharmacokinetic analysis of continuous infusion beta-lactam antibiotics (CIBL-PK) for CF exacerbations Co-Investigator Multi-centered, retrospective pharmacokinetic and pharmacodynamic analysis Pharmacokinetic/Pharmacodynamic (PK-PD) analysis of tobramycin cystic fibrosis patients Principal Investigator Multi-centered, retrospective pharmacokinetic and pharmacodynamic analysis A Survey of the Pharmacists Provided Care at U.S. CFF-accredited Centers Co-investigator Survey analysis of pharmacist care provided at CFF-accredited centers A Survey of the Pharmacist’s Role at U.S. CFF-accredited Centers Co-investigator Survey analysis of CFF Center Directors about role of pharmacists at their centers A Survey of the Utilization of Anti-Staphylococcal Antibiotics at U.S. CF Centers Principal Investigator Survey analysis of anti-staphylococcal utilization and dosing practices across the U.S. Sterility Analysis of Cystic Fibrosis Liquid Multivitamins Co-investigator Residency pilot study Survey of tobramycin and anti-pseudomonal beta-lactam antibiotics utilization in the treatment of pulmonary exacerbations in cystic fibrosis patients: A pharmacist approach Principal Investigator Survey analysis of tobramycin and anti-pseudomonal beta-lactam utilization and dosing practices among dedicated CF pharmacists across the U.S. 5/8/2017 Jeffery Zobell 12 Retrospective analysis of the rate of pneumococcal polysaccharide immunization in hospitalized pediatric asthma, cystic fibrosis, and congenital heart disease patients in Utah Principal investigator Retrospective study of pneumococcal immunization rates in high-risk populations Survey of utilization of anti-pseudomonal beta-lactam therapy in CF patients at U.S. CF Centers: follow-up Principal Investigator Survey analysis of anti-pseudomonal beta-lactam utilization and dosing practices across the U.S. as a follow-up study Assessment of the impact of pediatric knowledge by pharmacy students via a newly developed pediatric pharmacy curriculum Principal Investigator Questionnaire analysis of 3rd year pharmacy students at the University of Utah College of Pharmacy on pediatric knowledge Research Grants Clinical Pharmacy Research Award from the Primary Children’s Foundation for Sterility Analysis of Cystic Fibrosis Liquid Multivitamins Marriner S. Eccles Foundation Grant for The Impact of Individualized, Pharmacistprovided Asthma Education in an Asthma Care Pharmacy Professional Involvement Manuscript Reviewer: Journal of Pediatric Pharmacology and Therapeutics Pediatric Pulmonology Clinical Therapeutics Annals of Pharmacotherapy Coursemaster, PCTH 7320 Pediatric Pharmacotherapy Elective comprising of 15 lectures for 3rd year pharmacy students, The University of Utah College of Pharmacy Teach 3 lectures of course o Introduction to Course/Pediatrics 101/Age Definitions o Pediatric Pharmacokinetics & Pharmacodynamics o Pediatric Pulmonology: Cystic Fibrosis and Asthma Development of Cases and Exams Coordination of student shadow experience at Intermountain Primary Children’s Hospital Coordination of 4 non-didactic guest speaker lectures Pediatric Pharmacotherapy Module Leader comprising of 5 lectures in PCTH 7312 Drug and Disease Therapy II, The University of Utah College of Pharmacy 5/8/2017 Jeffery Zobell 13 Teach 1st 2 lectures of module o Introduction to Pediatric Pharmacy: Pediatric Age Groups, PK/PD differences o Pediatric Dosage Calculations, Therapeutic Drug Monitoring, and Pediatric Dosage Forms Development of Cases and Exam Instructor, PCTH 5113 Introduction to Pharmacy Practice, The University of Utah College of Pharmacy since 2008 Teach Basics of Pediatrics Workshop lecture Adjunct Assistant Professor in Pharmacotherapy, The University of Utah College of Pharmacy Faculty Advisor, Utah Pediatric Pharmacy Group (UPeds), Pediatric Pharmacy Advocacy Group Student Chapter at University of Utah College of Pharmacy Seminar Mentor, 2 Pharmacy students each semester from University of Utah College of Pharmacy Clinical Instructor in Pharmacy Practice and Science, The University of Arizona College of Pharmacy Affiliate Faculty, Idaho State University College of Pharmacy Co-coordinator, North American Cystic Fibrosis Foundation Pharmacist Mentorship Program Honors and Awards 2014 Leadership Excellence Awards in Pharmacy (L.E.A.P) Silver Award Winner, Baxter Healthcare, American Health-Systems Pharmacy Midyear Meeting, Anaheim, California 2014 Nominated for University of Utah College of Pharmacy P3 Teacher of the Year 2014 Nominated for University of Utah College of Pharmacy Preceptor of the Year 2014 Nominated for University of Utah College of Pharmacy P4 Teacher of the Year 2013 Nominated for University of Utah College of Pharmacy P3 Teacher of the Year 5/8/2017 Jeffery Zobell 14 2013 Nominated for University of Utah College of Pharmacy Preceptor of the Year 2012 Nominated for University of Utah College of Pharmacy Preceptor of the Year 2012 Carol Wood Spirit Award: Appreciation for the passionate care shown to cystic fibrosis patients and their families and for being a significant advocate for patients with CF, Cystic Fibrosis Foundation 2011 Intermountain Primary Children’s Medical Center PGY-1 Residency Preceptor of Year 2008 Cystic Fibrosis Foundation Quality Care Award: Recognizing Outstanding QI Processes and Accomplishments given to the Intermountain Cystic Fibrosis Center and the University of Utah Health Sciences Center, North American Cystic Fibrosis Conference, Orlando, Florida. 2006 Merck Pharmaceuticals Highest Scholastic Achievement Award, The University of Arizona, College of Pharmacy, Tucson, Arizona 2006 Mylan Pharmaceuticals Excellence in Drug Information Award, The University of Arizona, College of Pharmacy, Tucson, Arizona 2005 Paul A. and Helen L. Portteus Scholarship for the Most Outstanding 4th Year College of Pharmacy student (highest academic achievement), The University of Arizona, College of Pharmacy, Tucson, Arizona Professional Memberships Rho Chi Pharmacy Honor Society, Alpha Psi Chapter Pediatric Pharmacy Advocacy Group (PPAG) Special Skills, Licensure, Certifications, Leadership, Volunteer, and Experiences Language Skills: Fluent in conversational Portuguese Licensure: Arizona Pharmacy License #015484 expires 10/31/2016 Utah Pharmacy License #6193395-1701 expires 09/30/2015 Utah Pharmacy Controlled Substance License #6193395-8911 expires 09/30/2015 National Provider Identifier Number (NPI): 1801290986 5/8/2017 Jeffery Zobell 15 Certification: Basic Life Support (BLS) expires Feb 2016 Leadership: Lead Resident for 2006-2007 residency years, Intermountain Healthcare Pharmacy Practice Residency program (consisting of nine residents) Volunteer Youth soccer coach for Kaysville Parks and Recreation Youth baseball coach for Kaysville Parks and Recreation Experience: Two-year service mission for The Church of Jesus Christ of Latter-day Saints in Ribeirao Preto, Brazil References: Available upon request 5/8/2017